Gallbladder cancer laboratory tests: Difference between revisions
Jump to navigation
Jump to search
| Line 6: | Line 6: | ||
There are no [[diagnostic]] laboratory findings associated with [[gallbladder cancer]] | There are no [[diagnostic]] laboratory findings associated with [[gallbladder cancer]] | ||
==Laboratory tests<ref name="pmid2335386">{{cite journal |vauthors=Strom BL, Maislin G, West SL, Atkinson B, Herlyn M, Saul S, Rodriguez-Martinez HA, Rios-Dalenz J, Iliopoulos D, Soloway RD |title=Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer? |journal=Int. J. Cancer |volume=45 |issue=5 |pages=821–4 |year=1990 |pmid=2335386 |doi= |url=}}</ref> <ref name="pmid21573879">{{cite journal |vauthors=Rana S, Dutta U, Kochhar R, Rana SV, Gupta R, Pal R, Jain K, Srinivasan R, Nagi B, Nain CK, Singh K |title=Evaluation of CA 242 as a tumor marker in gallbladder cancer |journal=J Gastrointest Cancer |volume=43 |issue=2 |pages=267–71 |year=2012 |pmid=21573879 |doi=10.1007/s12029-011-9288-7 |url=}}</ref> | ==Laboratory tests== | ||
* Laboratory studies are usually nondiagnostic.<ref name="pmid2335386">{{cite journal |vauthors=Strom BL, Maislin G, West SL, Atkinson B, Herlyn M, Saul S, Rodriguez-Martinez HA, Rios-Dalenz J, Iliopoulos D, Soloway RD |title=Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer? |journal=Int. J. Cancer |volume=45 |issue=5 |pages=821–4 |year=1990 |pmid=2335386 |doi= |url=}}</ref><ref name="pmid21573879">{{cite journal |vauthors=Rana S, Dutta U, Kochhar R, Rana SV, Gupta R, Pal R, Jain K, Srinivasan R, Nagi B, Nain CK, Singh K |title=Evaluation of CA 242 as a tumor marker in gallbladder cancer |journal=J Gastrointest Cancer |volume=43 |issue=2 |pages=267–71 |year=2012 |pmid=21573879 |doi=10.1007/s12029-011-9288-7 |url=}}</ref> | |||
* An elevated [[alkaline phosphatase]] or serum [[bilirubin]] can be associated with [[bile duct]] [[obstruction]]. | * An elevated [[alkaline phosphatase]] or serum [[bilirubin]] can be associated with [[bile duct]] [[obstruction]]. | ||
* Serum [[tumor marker]]<nowiki/>s including carcinoembryonic antigen ([[CEA]]) or [[carbohydrate]] [[antigen]] 19-9 are frequently elevated, but they're no longer diagnostically useful because they lack [[specificity]] and [[sensitivity]]. | * Serum [[tumor marker]]<nowiki/>s including carcinoembryonic antigen ([[CEA]]) or [[carbohydrate]] [[antigen]] 19-9 are frequently elevated, but they're no longer diagnostically useful because they lack [[specificity]] and [[sensitivity]]. | ||
* CA 242 is a tumor marker for gallbladder cancer and performs better than CEA and [[CA 19-9]] | * CA 242 is a tumor marker for gallbladder cancer and performs better than CEA and [[CA 19-9]]. | ||
* However, if a tumor marker is observed to be elevated preoperatively, serial assay after resection may useful resource within the analysis of chronic or recurrent disease. | * However, if a tumor marker is observed to be elevated preoperatively, serial assay after resection may useful resource within the analysis of chronic or recurrent disease. | ||
Revision as of 18:56, 28 February 2018
|
Gallbladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gallbladder cancer laboratory tests On the Web |
|
American Roentgen Ray Society Images of Gallbladder cancer laboratory tests |
|
Risk calculators and risk factors for Gallbladder cancer laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
There are no diagnostic laboratory findings associated with gallbladder cancer
Laboratory tests
- Laboratory studies are usually nondiagnostic.[1][2]
- An elevated alkaline phosphatase or serum bilirubin can be associated with bile duct obstruction.
- Serum tumor markers including carcinoembryonic antigen (CEA) or carbohydrate antigen 19-9 are frequently elevated, but they're no longer diagnostically useful because they lack specificity and sensitivity.
- CA 242 is a tumor marker for gallbladder cancer and performs better than CEA and CA 19-9.
- However, if a tumor marker is observed to be elevated preoperatively, serial assay after resection may useful resource within the analysis of chronic or recurrent disease.
References
- ↑ Strom BL, Maislin G, West SL, Atkinson B, Herlyn M, Saul S, Rodriguez-Martinez HA, Rios-Dalenz J, Iliopoulos D, Soloway RD (1990). "Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer?". Int. J. Cancer. 45 (5): 821–4. PMID 2335386.
- ↑ Rana S, Dutta U, Kochhar R, Rana SV, Gupta R, Pal R, Jain K, Srinivasan R, Nagi B, Nain CK, Singh K (2012). "Evaluation of CA 242 as a tumor marker in gallbladder cancer". J Gastrointest Cancer. 43 (2): 267–71. doi:10.1007/s12029-011-9288-7. PMID 21573879.